Rapport Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 08/13/2026 | 7.17 M | $298.89 M | 0.06% | 15.11% |
| TRV GP V, LLC | 08/10/2026 | 6.28 M | $261.71 M | -11.98% | 13.23% |
| ARCH VENTURE MANAGEMENT, LLC | 08/14/2026 | 3.73 M | $155.38 M | 0.00% | 7.85% |
| CAPITAL INTERNATIONAL INVESTORS | 08/12/2026 | 2.92 M | $121.76 M | -5.68% | 6.16% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 2.91 M | $121.28 M | -1.08% | 6.13% |
| BLACKROCK, INC. | 08/07/2026 | 2.70 M | $112.50 M | 7.73% | 5.69% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2026 | 2.66 M | $110.74 M | -10.14% | 5.60% |
| SOFINNOVA INVESTMENTS, INC. | 08/14/2026 | 1.90 M | $79.36 M | 0.00% | 4.01% |
| JOHNSON & JOHNSON | 08/06/2026 | 1.78 M | $74.36 M | 0.00% | 3.76% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2026 | 1.61 M | $67.03 M | -2.07% | 3.39% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 1.55 M | $64.47 M | 0.00% | 3.26% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 1.35 M | $56.11 M | 1.62% | 2.84% |
| TRV GP VI, LLC | 08/10/2026 | 969.22 K | $40.39 M | 0.00% | 2.04% |
| STATE STREET CORP | 08/07/2026 | 818.71 K | $34.12 M | 7.79% | 1.72% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 793.45 K | $33.07 M | 9.95% | 1.67% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 787.45 K | $32.81 M | -9.12% | 1.66% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 773.34 K | $32.23 M | 14.75% | 1.63% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 730.00 K | $30.42 M | -49.17% | 1.54% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 693.38 K | $21.70 M | -4.73% | 1.46% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/13/2026 | 644.08 K | $26.84 M | -29.90% | 1.36% |
| SIREN, L.L.C. | 08/13/2026 | 641.47 K | $26.73 M | 0.00% | 1.35% |
| CAPITAL WORLD INVESTORS | 08/12/2026 | 551.66 K | $22.99 M | 2.80% | 1.16% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 393.20 K | $16.39 M | -36.64% | 0.83% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 362.11 K | $15.09 M | 61.30% | 0.76% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 359.94 K | $15.00 M | 12.16% | 0.76% |
| CANDRIAM S.C.A. | 08/13/2026 | 347.65 K | $14.47 M | 86.98% | 0.73% |
| SIO CAPITAL MANAGEMENT, LLC | 08/14/2026 | 307.66 K | $12.82 M | -16.13% | 0.65% |
| MORGAN STANLEY | 08/13/2026 | 297.61 K | $12.40 M | 79.33% | 0.63% |
| NORTHERN TRUST CORP | 08/13/2026 | 277.31 K | $11.56 M | 16.52% | 0.58% |
| KENNEDY CAPITAL MANAGEMENT LLC | 08/14/2026 | 250.80 K | $10.45 M | -2.58% | 0.53% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 08/14/2026 | 250.00 K | $10.42 M | 0.00% | 0.53% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 246.82 K | $10.28 M | 2.88% | 0.52% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 246.82 K | $10.28 M | 100.00% | 0.52% |
| ALGERT GLOBAL LLC | 08/13/2026 | 223.82 K | $9.33 M | 100.00% | 0.47% |
| INVESCO LTD. | 08/14/2026 | 215.24 K | $8.97 M | 25.31% | 0.45% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 214.83 K | $8.95 M | 22.45% | 0.45% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 208.33 K | $8.68 M | 10.08% | 0.44% |
| ENSIGN PEAK ADVISORS, INC | 08/14/2026 | 165.55 K | $6.90 M | -14.75% | 0.35% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 154.91 K | $6.46 M | -51.52% | 0.33% |
| UBS GROUP AG | 08/13/2026 | 151.17 K | $6.30 M | -0.38% | 0.32% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 150.00 K | $6.25 M | 0.00% | 0.32% |
| ARTIA GLOBAL PARTNERS LP | 08/14/2026 | 138.51 K | $5.77 M | 0.00% | 0.29% |
| SWEDBANK AB | 07/15/2026 | 117.40 K | $4.89 M | 3.71% | 0.25% |
| NUVEEN, LLC | 08/11/2026 | 103.36 K | $4.31 M | 44.54% | 0.22% |
| WALLEYE CAPITAL LLC | 08/03/2026 | 102.16 K | $4.26 M | 816.42% | 0.22% |
| WOODLINE PARTNERS LP | 08/14/2026 | 97.54 K | $4.06 M | 100.00% | 0.21% |
| TD ASSET MANAGEMENT INC | 08/04/2026 | 91.88 K | $3.83 M | -7.27% | 0.19% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 86.99 K | $3.62 M | 11.19% | 0.18% |
| PRUDENTIAL FINANCIAL INC | 08/12/2026 | 86.89 K | $3.62 M | -24.33% | 0.18% |
| CITADEL ADVISORS LLC | 09/02/2026 | 82.44 K | $3.44 M | 100.00% | 0.17% |
Rapport Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 183 institutional investors and hedge funds held shares of Rapport Therapeutics Inc.. The most heavily invested institutionals were:
FMR LLC: 7.17 M
TRV GP V, LLC: 6.28 M
ARCH Venture Management, LLC: 3.73 M
Capital International Investors: 2.92 M
GOLDMAN SACHS GROUP INC: 2.91 M
BlackRock, Inc.: 2.7 M
108.52% of Rapport Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 53.37 M shares in the last 24 months. This purchase volume represents approximately $1.63 B in transactions.